Symbols

OCEA(Delisted)

Ocean Biomedical·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About OCEA

Ocean Biomedical, Inc.

A company that provides preventive and therapeutic drug services for lung cancer, brain cancer, pulmonary fibrosis and malaria

Industry

Established Date

Listing Date

11/08/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.oceanbiomedical.com

Security Type

Common stock

Office address

55 Claverick St., Room 325, Providence, RI 02903

Business

Introduction

Ocean Biomedical, Inc., is incorporated as a Delaware corporation. The company is a Providence, Rhode Island-based biopharmaceutical company whose innovative business model accelerates the development and commercialization of scientifically attractive assets in research universities and medical centers. Ocean Biomedical leverages capital and expertise to effectively move new therapeutic candidates from the laboratory to the clinic and around the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to transform people's lives in the prevention and treatment of lung cancer, brain cancer, pulmonary fibrosis, and malaria.

Company Financials

EPS

OCEA has released its 2023 Q2 earnings. EPS was reported at -0.49, versus the expected -0.2, missing expectations. The chart below visualizes how OCEA has performed over recent quarters, highlighting trends in earnings surprises.